Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.
Lapid MI, Merrill J, Mueller M, Hermida AP, Nykamp L, Andrus J, Azizi H, Bolton P, Bonsu N, Braga R, Dillon CR, Ecklesdafer D, Evans D, Harper D, Heintz H, Hussain-Krauter S, Holzgen O, Humphrey D, Jiwani S, Johnson EK, Kang S, Kassien J, Kim J, Knapp RG, Kung S, Kremen N, Le K, Mahdasian J, Marzouk T, Masrud JD, Mattingly J, Miller D, Pagali SR, Patrick R, Riva Posse P, Pritchett C, Rahman A, Rath S, Roczniak C, Rummans TA, Sanghani S, Seiner S, Smart L, Tomaschek E, Tsygankova V, VanderSchuur-White L, Walton MP, Wilkins J, Williams A, Williams SM, Petrides G, Forester BP. Lapid MI, et al. Among authors: johnson ek. PLoS One. 2024 Jun 28;19(6):e0303894. doi: 10.1371/journal.pone.0303894. eCollection 2024. PLoS One. 2024. PMID: 38941338 Free PMC article. Clinical Trial.
Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials.
McManus KR, Lapid MI, Forester BP, Mueller M, Hermida AP, Nykamp L, Harper DG, Seiner SJ, Sanghani S, Patrick R, Gentry MT, Kung S, Leal JC, Johnson EK, Petrides G. McManus KR, et al. Among authors: johnson ek. J ECT. 2022 Sep 1;38(3):165-170. doi: 10.1097/YCT.0000000000000832. Epub 2022 Mar 1. J ECT. 2022. PMID: 35220356 Free PMC article. Clinical Trial.
Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment.
Schak KM, Vande Voort JL, Johnson EK, Kung S, Leung JG, Rasmussen KG, Palmer BA, Frye MA. Schak KM, et al. Among authors: johnson ek. Am J Psychiatry. 2016 Mar 1;173(3):215-8. doi: 10.1176/appi.ajp.2015.15081082. Am J Psychiatry. 2016. PMID: 26926127 No abstract available.
Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164.
Joseph B, Nunez NA, Kung S, Vande Voort JL, Pazdernik VK, Schak KM, Boehm SM, Carpenter B, Johnson EK, Malyshev G, Smits N, Adewunmi DO, Brown SK, Singh B. Joseph B, et al. Among authors: johnson ek. Pharmaceuticals (Basel). 2023 Nov 7;16(11):1571. doi: 10.3390/ph16111571. Pharmaceuticals (Basel). 2023. PMID: 38004498 Free PMC article.
Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey.
Leung JG, Cusimano J, Gannon JM, Milgrom O, Valcourt SC, Stoklosa JB, Kemp M, Olsufka W, Vickery PB, Nichols SD, Crouse EL, Paxos C, Johnson EK, Palmer BA. Leung JG, et al. Among authors: johnson ek. Int Clin Psychopharmacol. 2019 Sep;34(5):247-256. doi: 10.1097/YIC.0000000000000269. Int Clin Psychopharmacol. 2019. PMID: 31107831
383 results